NCT04849299 - Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 18, 2021

Primary Completion Date

May 10, 2021

Study Completion Date

May 10, 2021

Conditions

Healthy Volunteer Study

Interventions

DRUG

AT-527 550 mg + cyclosporine

550 mg AT-527 alone on Day 1 and 550 mg AT-527 plus 600 mg cyclosporine administered simultaneously on Day 7 Other Names: AT-527 is also known as R07496998

DRUG

AT-527 550 mg + cyclosporine

550 mg AT-527 alone on Day 1 and 550 mg AT-527 plus 600 mg cyclosporine administered on Day 7 (with dosing offset by 2 hrs) Other Names: AT-527 is also known as R07496998

Trial Locations (1)

Unknown

Atea Study Site, Montreal